Precision BioSciences Inc... (DTIL)
Precision BioSciences Statistics
Share Statistics
Precision BioSciences has 7.89M shares outstanding. The number of shares has increased by 10.91% in one year.
| Shares Outstanding | 7.89M |
| Shares Change (YoY) | 10.91% |
| Shares Change (QoQ) | 6.05% |
| Owned by Institutions (%) | 30.52% |
| Shares Floating | 6.72M |
| Failed to Deliver (FTD) Shares | 8 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 912.07K, so 11.56% of the outstanding shares have been sold short.
| Short Interest | 912.07K |
| Short % of Shares Out | 11.56% |
| Short % of Float | 12.89% |
| Short Ratio (days to cover) | 0.73 |
Valuation Ratios
The PE ratio is 3.63 and the forward PE ratio is -0.58. Precision BioSciences's PEG ratio is -0.03.
| PE Ratio | 3.63 |
| Forward PE | -0.58 |
| PS Ratio | 0.38 |
| Forward PS | 0.8 |
| PB Ratio | 0.46 |
| P/FCF Ratio | -0.44 |
| PEG Ratio | -0.03 |
Enterprise Valuation
Precision BioSciences Inc. has an Enterprise Value (EV) of -43.35M.
| EV / Earnings | -6.05 |
| EV / Sales | -0.63 |
| EV / EBITDA | -6.05 |
| EV / EBIT | -6.05 |
| EV / FCF | 0.74 |
Financial Position
The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.34 |
| Quick Ratio | 6.34 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 2.29 |
| Cash Flow / Debt | -44.28 |
| Interest Coverage | -4.02 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 12.42%.
| Return on Equity (ROE) | 0.13% |
| Return on Assets (ROA) | 0.05% |
| Return on Capital (ROIC) | 12.42% |
| Revenue Per Employee | $636,074.07 |
| Profits Per Employee | $66,361.11 |
| Employee Count | 108 |
| Asset Turnover | 0.5 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -66.22% in the last 52 weeks. The beta is 1.59, so Precision BioSciences's price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | -66.22% |
| 50-Day Moving Average | 5.11 |
| 200-Day Moving Average | 7.63 |
| Relative Strength Index (RSI) | 37.33 |
| Average Volume (20 Days) | 507.7K |
Income Statement
In the last 12 months, Precision BioSciences had revenue of 68.7M and earned 7.17M in profits. Earnings per share was 1.05.
| Revenue | 68.7M |
| Gross Profit | 68.7M |
| Operating Income | 7.17M |
| Net Income | 7.17M |
| EBITDA | 7.17M |
| EBIT | 7.17M |
| Earnings Per Share (EPS) | 1.05 |
Balance Sheet
The company has 85.9M in cash and 1.32M in debt, giving a net cash position of 84.58M.
| Cash & Cash Equivalents | 85.9M |
| Total Debt | 1.32M |
| Net Cash | 84.58M |
| Retained Earnings | -482.46M |
| Total Assets | 153.26M |
| Working Capital | 98.54M |
Cash Flow
In the last 12 months, operating cash flow was -58.45M and capital expenditures -250K, giving a free cash flow of -58.7M.
| Operating Cash Flow | -58.45M |
| Capital Expenditures | -250K |
| Free Cash Flow | -58.7M |
| FCF Per Share | -8.59 |
Margins
Gross margin is 100%, with operating and profit margins of 10.43% and 10.43%.
| Gross Margin | 100% |
| Operating Margin | 10.43% |
| Pretax Margin | 10.43% |
| Profit Margin | 10.43% |
| EBITDA Margin | 10.43% |
| EBIT Margin | 10.43% |
| FCF Margin | -85.44% |
Dividends & Yields
DTIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 22.93% |
| FCF Yield | -162.39% |
Analyst Forecast
The average price target for DTIL is $34, which is 642.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $34 |
| Price Target Difference | 642.4% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Feb 14, 2024. It was a backward split with a ratio of 1:30.
| Last Split Date | Feb 14, 2024 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -2.42 |
| Piotroski F-Score | 4 |